1098-1136/asset/olbannerleft.gif?v=1&s=e6cb8ca99635b2d8dee48149272e1b077a90e920)
1098-1136/asset/olbannerright.gif?v=1&s=dc97874dbe766e01003f28699692b2a04222fcbd)
Original Article
You have free access to this content
Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide
Article first published online: 28 DEC 2002
DOI: 10.1002/glia.10177
Copyright © 2003 Wiley-Liss, Inc.
1098-1136/asset/cover.gif?v=1&s=b114b545ff9d0c121aa97dba7ad0e42e4d685594 "Glia")
Additional Information
How to Cite
Facchinetti, F., Del Giudice, E., Furegato, S., Passarotto, M. and Leon, A. (2003), Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide. Glia, 41: 161–168. doi: 10.1002/glia.10177
Publication History
- Issue published online: 28 DEC 2002
- Article first published online: 28 DEC 2002
- Manuscript Accepted: 13 SEP 2002
- Manuscript Received: 7 MAR 2002
Funded by
- Italian Ministry of Education, University and Research Ministry (MIUR). Grant Number: 3933
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells, European Journal of Pharmacology, 2012, 682, 1-3, 62
- 2, , , , , , , Cannabinoid CB2 receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide, British Journal of Pharmacology, 2012, 165, 6Direct Link:
- 3, , , Impact of Cannabis Treatment on the Quality of Life, Weight and Clinical Disease Activity in Inflammatory Bowel Disease Patients: A Pilot Prospective Study, Digestion, 2012, 85, 1, 1
- 4, , , , , , , , Pharmacological inhibition of endocannabinoid degradation modulates the expression of inflammatory mediators in the hypothalamus following an immunological stressor, Neuroscience, 2012, 204, 53
- 5, , , , A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells, Journal of Pharmacy and Pharmacology, 2011, 63, 5Direct Link:
- 6, , , , , , , HIV-1 infection and alcohol abuse: Neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions, Brain, Behavior, and Immunity, 2011, 25, S61
- 7, , , Immunomodulatory Properties of Kappa Opioids and Synthetic Cannabinoids in HIV-1 Neuropathogenesis, Journal of Neuroimmune Pharmacology, 2011, 6, 4, 528
- 8, , , , , , Pathophysiology and Treatment Options for Cardiac Anorexia, Current Heart Failure Reports, 2011, 8, 2, 147
- 9, , , , Positron emission tomography imaging in multiple sclerosis–current status and future applications, European Journal of Neurology, 2011, 18, 2Direct Link:
- You have free access to this content10, , , , , The dual neuroprotective–neurotoxic profile of cannabinoid drugs, British Journal of Pharmacology, 2011, 163, 7Direct Link:
- 11, , , , The endocannabinoid arachidonylethanolamide attenuates aspects of lipopolysaccharide-induced changes in energy intake, energy expenditure and hypothalamic Fos expression, Journal of Neuroimmunology, 2011, 233, 1-2, 127
- 12, , , , , , , , , Time-dependent expression and distribution of monoacylglycerol lipase during the skin-incised wound healing in mice, International Journal of Legal Medicine, 2011, 125, 4, 549
- You have free access to this content13, Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas, Glia, 2010, 58, 9Direct Link:
- 14, , Cannabinoids and the gut: New developments and emerging concepts, Pharmacology & Therapeutics, 2010, 126, 1, 21
- 15, , , , , , , Immunoregulation of a CB2 Receptor Agonist in a Murine Model of NeuroAIDS, Journal of Neuroimmune Pharmacology, 2010, 5, 3, 456
- 16, , , , , , Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development, Neuroscience, 2010, 166, 2, 464
- 17, , , , , Participation of the endocannabinoid system in lipopolysaccharide-induced inhibition of salivary secretion, Archives of Oral Biology, 2010, 55, 8, 583
- 18, , , , , , , , , Purinergic receptor-mediated morphological changes in microglia are transient and independent from inflammatory cytokine release, European Journal of Pharmacology, 2010, 643, 2-3, 202
- 19, , , , The endocannabinoid 2-arachidonylglycerol is a negative allosteric modulator of the human A3 adenosine receptor, Biochemical Pharmacology, 2010, 79, 1, 48
- 20, , , , The endocannabinoid system in gp120-mediated insults and HIV-associated dementia, Experimental Neurology, 2010, 224, 1, 74
- 21, , , The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis, Experimental Neurology, 2010, 224, 1, 92
- 22, , , , , , 2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells, Glia, 2009, 57, 3Direct Link:
- 23, , , , , , , Cannabinoids prevent the opposite regulation of astroglial connexin43 hemichannels and gap junction channels induced by pro-inflammatory treatments, Journal of Neurochemistry, 2009, 111, 6Direct Link:
- 24, , , , Cannabinoids, multiple sclerosis and neuroprotection, Expert Review of Clinical Pharmacology, 2009, 2, 6, 645
- 25
- 26, Physiological roles of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, BioFactors, 2009, 35, 1Direct Link:
- 27, , , , Silica-Based Nanoparticle Uptake and Cellular Response by Primary Microglia, Environmental Health Perspectives, 2009, 118, 5, 589
- 28, , , , , , The endocannabinoid anandamide inhibits potassium conductance in rat cortical astrocytes, Glia, 2009, 57, 7Direct Link:
- 29
- 30, , , , A COX-2 metabolite of the endogenous cannabinoid, 2-arachidonyl glycerol, mediates suppression of IL-2 secretion in activated Jurkat T cells, Biochemical Pharmacology, 2008, 76, 3, 353
- You have free access to this content31, , , , , , , , , A Saturated N-Acylethanolamine Other than N-Palmitoyl Ethanolamine with Anti-inflammatory Properties: a Neglected Story…, Journal of Neuroendocrinology, 2008, 20,Direct Link:
- 32, , , , Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide-induced alterations in circulating cytokine levels in rats, Immunology, 2008, 125, 2Direct Link:
- 33, , , , , , Cannabinoid CB2 receptors in human brain inflammation, British Journal of Pharmacology, 2008, 153, 2Direct Link:
- 34, , , , Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats, Neurobiology of Aging, 2008, 29, 12, 1894
- 35, , , , , , , Delta-9-tetrahydrocannabinol accumulation, metabolism and cell-type-specific adverse effects in aggregating brain cell cultures, Toxicology and Applied Pharmacology, 2008, 228, 1, 8
- 36, , , , , , , Evidence for a novel functional role of cannabinoid CB2 receptors in the thalamus of neuropathic rats, European Journal of Neuroscience, 2008, 27, 7Direct Link:
- 37, GASTROINTESTINAL ENDOCANNABINOID SYSTEM: MULTIFACETED ROLES IN THE HEALTHY AND INFLAMED INTESTINE, Clinical and Experimental Pharmacology and Physiology, 2008, 35, 11Direct Link:
- 38, , , Inflammation and aging: Can endocannabinoids help?, Biomedicine & Pharmacotherapy, 2008, 62, 4, 212
- 39, , , , , , , , , , , Release of arachidonic acid by 2-arachidonoyl glycerol and HU210 in PC12 cells; roles of Src, phospholipase C and cytosolic phospholipase A2α, European Journal of Pharmacology, 2008, 590, 1-3, 1
- 40, , , , , Role of CB2 receptors in neuroprotective effects of cannabinoids, Molecular and Cellular Endocrinology, 2008, 286, 1-2, S91
- 41, , , The Cytokine Basis of Cachexia and its Treatment: Are They Ready for Prime Time?, Journal of the American Medical Directors Association, 2008, 9, 4, 219
- 42, , Alzheimer's disease; taking the edge off with cannabinoids?, British Journal of Pharmacology, 2007, 152, 5Direct Link:
- 43, , , Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation, Neuroscience, 2007, 144, 4, 1516
- 44, , , , , Cannabinoid CB2 Receptor-Mediated Anti-nociception in Models of Acute and Chronic Pain, Molecular Neurobiology, 2007, 36, 1, 26
- 45, , , , , , Cannabinoid CB2 receptor: a new target for controlling neural cell survival?, Trends in Pharmacological Sciences, 2007, 28, 1, 39
- 46, , , , , Cannabinoids and neuronal damage: Differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures, Experimental Neurology, 2007, 203, 1, 246
- 47, , , , , , Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain, Neuroscience Letters, 2007, 412, 2, 114
- 48, , , , , , , , , , , , Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism, Journal of Neurochemistry, 2007, 102, 5Direct Link:
- 49, , , Emerging drugs for cancer cachexia, Expert Opinion on Emerging Drugs, 2007, 12, 4, 555
- 50, Endocannabinoid system in cancer cachexia, Current Opinion in Clinical Nutrition and Metabolic Care, 2007, 10, 4, 443
- 51
- 52, , , Pharmacological Treatment of Geriatric Cachexia: Evidence and Safety in Perspective, Journal of the American Medical Directors Association, 2007, 8, 6, 363
- 53, , , , , , , , Roles of Transient Receptor Potential Vanilloid Subtype 1 and Cannabinoid Type 1 Receptors in the Brain: Neuroprotection versus Neurotoxicity, Molecular Neurobiology, 2007, 35, 3, 245
- 54, , The endocannabinoid system and its protective role in ischemic and cytotoxic injuries of brain neurons, Neurochemical Journal, 2007, 1, 2, 93
- 55, , , , , The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation, British Journal of Pharmacology, 2007, 152, 5Direct Link:
- 56, The Pharmacology of the Cannabinoid System—A Question of Efficacy and Selectivity, Molecular Neurobiology, 2007, 36, 1, 15
- 57
- 58, , Cannabinoid receptors and endocannabinoids: Evidence for new players, The AAPS Journal, 2006, 8, 2, E298
- 59, , Cannabinoid Receptors and Endocannabinoids: Evidence for New Players, The AAPS Journal, 2006, 08, 02, E298
- 60, , , , , Cannabinoid signalling in TNF-α induced IL-8 release, European Journal of Pharmacology, 2006, 540, 1-3, 183
- 61, , , , In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids, Journal of Neuroimmunology, 2006, 181, 1-2, 57
- 62, , , The cannabinoid agonist WIN 55,212-2 inhibits TNF-α-induced neutrophil transmigration across ECV304 cells, European Journal of Pharmacology, 2006, 547, 1-3, 165
- 63, , , , , , , , , , , The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells, Neuron, 2006, 49, 1, 67
- 64, , , , , , , WIN55,212-2-Mediated Inhibition of HIV-1 Expression in Microglial Cells: Involvement of Cannabinoid Receptors, Journal of Neuroimmune Pharmacology, 2006, 2, 2, 178
- 65, , , , Cannabinoid influence on cytokine profile in multiple sclerosis, Clinical & Experimental Immunology, 2005, 140, 3Direct Link:
- 66, Cannabinoid-based drugs as anti-inflammatory therapeutics, Nature Reviews Immunology, 2005, 5, 5, 400
- 67, , , , Cannabinoids and neuroprotection in CNS inflammatory disease, Journal of the Neurological Sciences, 2005, 233, 1-2, 21
- 68, , Endogenous cannabinoids − a local message in and between the nervous and immune system, Signal Transduction, 2005, 5, 1-2Direct Link:
- 69, , , , , , Peripheral injection of lipopolysaccharide enhances expression of inflammatory cytokines in murine locus coeruleus: possible role of increased norepinephrine turnover, Journal of Neurochemistry, 2005, 94, 2Direct Link:
- 70, , , , , , Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1β-stimulated human astrocytes, Glia, 2005, 49, 2Direct Link:
- 71
- 72, , Are cannabinoid drugs neurotoxic or neuroprotective?, Medical Hypotheses, 2004, 63, 2, 187
- 73, , , , , Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons, British Journal of Pharmacology, 2004, 142, 2Direct Link:
- 74, Cannabinoid signaling in glial cells, Glia, 2004, 48, 4Direct Link:
- 75, , Cannabinoids and neuroinflammation, British Journal of Pharmacology, 2004, 141, 5Direct Link:
- 76
- 77, Clinical Pharmacodynamics of Cannabinoids, Journal of Cannabis Therapeutics, 2004, 4, 1, 29
- 78, , , , Downregulation of class II transactivator (CIITA) expression by synthetic cannabinoid CP55,940, Immunology Letters, 2004, 91, 1, 11
- 79, , , , , , Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia?, Journal of Neurochemistry, 2004, 88, 5Direct Link:
- 80, , , , , Role of cannabinoid receptors in inhibiting macrophage costimulatory activity, International Immunopharmacology, 2004, 4, 2, 265
- 81, Tumor necrosis factor reduces cAMP production in rat microglia, Glia, 2004, 48, 3Direct Link:
- 82, , , , , , Selective modulation of lipopolysaccharide-stimulated cytokine expression and mitogen-activated protein kinase pathways by dibutyryl-cAMP in BV2 microglial cells, Molecular Brain Research, 2003, 113, 1-2, 86